Asia Rates: Flows, Positioning & Valuation (January 2023)
- FPI inflows are returning, and investor positioning is turning less bearish on Asia
- There are dispersions beneath the surface, driven by the China reopening theme
- IndoGBs are benefitting most. For China CGBs, the worst of foreign outflows are behind us
- Funds increased their UW on China bond duration, but cut their UW on CNY FX
- For IndoGB duration and IDR FX, fund managers turned OW in December
For charts and models referenced in report, click Download the PDF.
Risk sentiments towards Asian assets (equities, LC bonds, currencies) are staying supported on continued softness in the broad US Dollar and further declines in US rates. There is optimism that the US and Europe's recession risks would turn out to be milder than previously expected. Moreover, Asia’s growth would relatively outperform DM this year, allowing for a risk-on environment that is conducive to inflows and Asian asset performance.
When we look at recent inflows and fund positioning changes for Asian assets, investors are turning more bullish on Asia. But there has been some dispersion and China reopening is the dominant theme driving these dispersions. For 1H, we think that risk sentiments towards Asian assets will stay supported and investors should stay still positioned around the China reopening theme.
Bond and Equity Flows
For foreign inflows into Asia bonds, we have high frequency data only for the high yielders - Indonesia and India. Both are seeing larger-than-usual foreign inflows in January. Month-to-date, there has been a USD2.8bn increase in foreign holdings of IndoGBs, following December's USD1.6bn and November's USD1.5bn increases. With foreign positioning light (after many months of outflows prior), IndoGB would be a key beneficiary of the risk-on environment and carry-seeking inflows into EM. For India GSecs, foreign holdings of FAR and non-FAR bonds have risen by USD0.4bn and USD0.1bn respectively in January. GSecs likely stood out because bond yields have not fallen as much as in US or other of Asia, and thus, be seen as relatively cheap.
For China CGBs, the worst of foreign outflows are behind us. In December, foreign holdings of CGBs increased by USD3.4bn. Though there was a moderate amount of inflows, global investors are likely still hold a neutral-to-underweight stance on CGBs. The bulk of December's increase in foreign holdings could be due to passive index inflows from ongoing WGBI inclusion process (we estimate related monthly inflows to average USD3.5-4.0bn). If global investors turn bullish on CGBs, we would be expecting monthly inflows of at least USD7-8bn.
In the other parts of Asia government bond complex, Korea KTBs registered a small USD0.5bn decline in foreign holdings in December, likely due to tightening in asset-swap spreads. Short-term Thai debt securities (Treasury bills, BOT bonds) continue to see strong foreign demand in December, as a play on the potential for THB appreciation as tourism inflows recover further.
For Asia equities, we are seeing large foreign net purchases for Chinese and Korean equities in January, while inflows into Thai equities have been relatively more moderate. Focusing on Chinese equities, net purchases via Northbound Stock Connect have amounted to USD16.6bn month-to-date, representing likely the largest monthly inflows on record. To put into context, net purchases this month is more than net purchases over the whole of 2022 (USD13.4bn) and roughly one-quarter of net purchases over the whole of 2021 (USD67.3bn).
In contrast, we are seeing small foreign net sale of Indian, Indonesia and Malaysian equities in January. Some investors could have rotated out because these economies would benefit to a lesser extent from China's reopening and recovery, whether from the perspective of exports to China or inbound Chinese tourists.
Based on our valuation measures, excess risk premia in Asia bonds appear to have bottomed in September and valuations are gradually improving (becoming less rich) across the board. Valuations, are however, still relatively rich compared to one year ago (early 2022). Though the broader macro backdrop is supportive, Asia bonds' relatively rich valuations could be a limiting factor on the scope for further price gains.
Based on our tracking of EM LC bond funds, we find a few notable changes to fund positioning. In December, fund managers increased their underweight position on China bond duration to an extreme 3.4%, but they cut their underweight position on CNY FX to a smaller 1.7%. This seems reasonable, as China's reopening and recovery would be expected to drive bond yields higher (resulting in price losses in LC terms) and be near-term supportive for CNY FX. For IndoGB duration and IDR FX, fund managers turned overweight in December, after being underweight for the five months prior. IndoGBs (and IDR FX) are likely expected to disproportionately benefit and outperform from the return of carry-seeking inflows into EM.
Looking ahead, we expect fund managers to maintain large underweight positions on China bond duration, as the outlook is clearly for higher bond yields. Managers could turn less bearish on China bond duration in 3Q, when China recovery momentum in expected to peak. On IndoGBs and IDR FX, there is certainly room for managers to get more bullish/increase overweight position in the coming months, to levels that are comparable with current overweight positions for Brazil, Mexico and South Africa.
For 1H, we think that risk sentiments towards Asian assets will stay supported and the China reopening theme has further room to run. As we have written in our Annual Outlook, we are overweight Korea KTBs, IndoGBs and ThaiGBs. We think IndoGBs give the best exposure to better risk sentiments and returning bond inflows into EM. Korea KTBs and ThaiGBs could outperform around the China reopening theme, as both their economies have larger trade/tourism exposures to China.
To read the full report, click here to Download the PDF.
GENERAL DISCLOSURE/ DISCLAIMER (For Macroeconomics, Currencies, Interest Rates)
The information herein is published by DBS Bank Ltd and/or DBS Bank (Hong Kong) Limited (each and/or collectively, the “Company”). This report is intended for “Accredited Investors” and “Institutional Investors” (defined under the Financial Advisers Act and Securities and Futures Act of Singapore, and their subsidiary legislation), as well as “Professional Investors” (defined under the Securities and Futures Ordinance of Hong Kong) only. It is based on information obtained from sources believed to be reliable, but the Company does not make any representation or warranty, express or implied, as to its accuracy, completeness, timeliness or correctness for any particular purpose. Opinions expressed are subject to change without notice. This research is prepared for general circulation. Any recommendation contained herein does not have regard to the specific investment objectives, financial situation and the particular needs of any specific addressee. The information herein is published for the information of addressees only and is not to be taken in substitution for the exercise of judgement by addressees, who should obtain separate legal or financial advice. The Company, or any of its related companies or any individuals connected with the group accepts no liability for any direct, special, indirect, consequential, incidental damages or any other loss or damages of any kind arising from any use of the information herein (including any error, omission or misstatement herein, negligent or otherwise) or further communication thereof, even if the Company or any other person has been advised of the possibility thereof. The information herein is not to be construed as an offer or a solicitation of an offer to buy or sell any securities, futures, options or other financial instruments or to provide any investment advice or services. The Company and its associates, their directors, officers and/or employees may have positions or other interests in, and may effect transactions in securities mentioned herein and may also perform or seek to perform broking, investment banking and other banking or financial services for these companies. The information herein is not directed to, or intended for distribution to or use by, any person or entity that is a citizen or resident of or located in any locality, state, country, or other jurisdiction (including but not limited to citizens or residents of the United States of America) where such distribution, publication, availability or use would be contrary to law or regulation. The information is not an offer to sell or the solicitation of an offer to buy any security in any jurisdiction (including but not limited to the United States of America) where such an offer or solicitation would be contrary to law or regulation.
This report is distributed in Singapore by DBS Bank Ltd (Company Regn. No. 196800306E) which is Exempt Financial Advisers as defined in the Financial Advisers Act and regulated by the Monetary Authority of Singapore. DBS Bank Ltd may distribute reports produced by its respective foreign entities, affiliates or other foreign research houses pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Singapore recipients should contact DBS Bank Ltd at 65-6878-8888 for matters arising from, or in connection with the report.
This report has been prepared by a personnel of DBS Bank Ltd who is not licensed by the Hong Kong Securities and Futures Commission to carry on the regulated activity of advising on securities in Hong Kong pursuant to the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong). This report is being distributed in Hong Kong by DBS Bank Ltd, DBS Bank (Hong Kong) Limited and DBS Vickers (Hong Kong) Limited.
DBS Bank Ltd., 12 Marina Boulevard, Marina Bay Financial Centre Tower 3, Singapore 018982. Tel: 65-6878-8888. Company Registration No. 196800306E.
DBS Bank Ltd., Hong Kong Branch, a company incorporated in Singapore with limited liability. 18th Floor, The Center, 99 Queen’s Road Central, Central, Hong Kong SAR.
DBS Bank (Hong Kong) Limited, a company incorporated in Hong Kong with limited liability. 11th Floor, The Center, 99 Queen’s Road Central, Central, Hong Kong SAR.
Virtual currencies are highly speculative digital "virtual commodities", and are not currencies. It is not a financial product approved by the Taiwan Financial Supervisory Commission, and the safeguards of the existing investor protection regime does not apply. The prices of virtual currencies may fluctuate greatly, and the investment risk is high. Before engaging in such transactions, the investor should carefully assess the risks, and seek its own independent advice.